Theradiag Stock

ALTER

FR0004197747

Days

on all subscriptions*

Last days

Enjoy this offer

* See conditions under "Our services"

News in other languages: Theradiag

23-12-20	Theradiag : Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
23-12-18	Biosynex : réalisation de la fusion-absorption de Theradiag
23-12-18	Bolsa de Madrid: Los bancos centrales se lanzan a por los toros
23-12-18	Capelli : Eiffage, Renault, Tikehau Capital... les valeurs à suivre aujourd'hui à Paris
23-12-18	En Direct des Marchés : Vivendi, Teleperformance, Renault, Carrefour, Casino, Eurazeo, Unilever...

More news

Managers and Directors: Theradiag

Manager	Title	Age	Since
Bertrand Michel Marle de Castelnau CEO	Chief Executive Officer	65	2019-01-20
Muriel Bardet DFI	Director of Finance/CFO	-	-

Director	Title	Age	Since
Christian Policard CHM	Chairman	-	-
Thierry Paper BRD	Director/Board Member	63	2022-05-04
Larry Abensur BRD	Director/Board Member	71	2022-05-04

More insiders

Theradiag develops, produces, and sells in vitro diagnostic kits for detecting auto-immune diseases, allergies, and infectious diseases. The group also offers theranostic tests for monitoring biotherapies and determining patient response to treatments applied. 54.6% of net sales are abroad.

Employees

Sector

More about the company

23-12-18	Biosynex: merger with Theradiag completed
23-09-21	Theradiag SA Reports Earnings Results for the Half Year Ended June 30, 2023	CI
23-09-18	Theradiag: improved first-half profitability
23-07-17	Theradiag: 7% growth in half-year sales
23-07-17	Theradiag SA Reports Audited Revenue Results for the Second Quarter and First Half Ended on June 30, 2023	CI
23-04-26	Theradiag SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI
23-03-01	Theradiag SA Announces Executive Changes	CI
23-03-01	Theradiag SA Announces Management Changes	CI
23-01-30	Biosynex SA completed the acquisition of additional 46.52% stake in Theradiag SA for €21.6 million.	CI
23-01-18	Biosynex: takeover bid reopened for Theradiag shares
23-01-17	Theradiag: takeover bid reopened on January 18
23-01-16	Theradiag: 2022 sales without surprises
23-01-16	Biosynex: successful takeover bid for Theradiag

23-11-17	Q-linea signs distribution partnership for Benelux	AQ
23-01-16	Theradiag : Inside Information / News release on accounts, results	PU
23-01-06	Theradiag : Inside Information / Other news releases	PU
22-09-23	Theradiag : News releases during takeover bids / Takeover bids Other news releases	PU
21-10-26	26/10/2021: Theradiag launches a Rights Issue	PU

Theradiag Stock

Stocks

ALTER

FR0004197747

Latest news : Theradiag

Press Releases: Theradiag

News in other languages: Theradiag

Managers and Directors: Theradiag

Latest insider transactions

Company Profile